Cargando…

The macrophage-associated microRNA-4715-3p / Gasdermin D axis potentially indicates fibrosis progression in nonalcoholic fatty liver disease: evidence from transcriptome and biological data

Nonalcoholic fatty liver disease (NAFLD) is highly possible to progress to cirrhosis, malignancy, and liver failure through fibrogenesis. The enormous potential of pathogenetic and therapeutic targets in NAFLD has been revealed. This study aimed to explore novel factors potentially indicating or med...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Shuai, Cai, Xiurong, Liu, Yu, Shen, Yu, Guillot, Adrien, Tacke, Frank, Tang, Liming, Liu, Hanyang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275955/ https://www.ncbi.nlm.nih.gov/pubmed/35521691 http://dx.doi.org/10.1080/21655979.2022.2072602

Ejemplares similares

Nuclear Receptors Linking Metabolism, Inflammation, and Fibrosis in Nonalcoholic Fatty Liver Disease
por: Puengel, Tobias, et al.
Publicado: (2022)

The contradictory roles of macrophages in non-alcoholic fatty liver disease and primary liver cancer—Challenges and opportunities
por: Kohlhepp, Marlene Sophia, et al.
Publicado: (2023)

Bariatric Surgery Associates with Nonalcoholic Steatohepatitis/Hepatocellular Carcinoma Amelioration via SPP1 Suppression
por: Chen, Shuai, et al.
Publicado: (2022)

Cholangiokines: undervalued modulators in the hepatic microenvironment
por: Cai, Xiurong, et al.
Publicado: (2023)

Cellular Senescence in Hepatocellular Carcinoma: The Passenger or the Driver?
por: Cai, Xiurong, et al.
Publicado: (2022)

XPG is Modulated by miR-4715-3p and rs873601 Genotypes in Lung Cancer
por: Yu, WeiLing, et al.
Publicado: (2021)

Liver Macrophages: Old Dogmas and New Insights
por: Guillot, Adrien, et al.
Publicado: (2019)

Epigenetic regulation of AURKA by miR-4715-3p in upper gastrointestinal cancers
por: Gomaa, Ahmed, et al.
Publicado: (2019)

Modeling Nonalcoholic Fatty Liver Disease in the Dish Using Human-Specific Platforms: Strategies and Limitations
por: Rezvani, Milad, et al.
Publicado: (2023)

Complete Genome Sequences of the Xylose-Fermenting Candida intermedia Strains CBS 141442 and PYCC 4715
por: Moreno, Antonio D., et al.
Publicado: (2017)

Molecular and Cellular Mediators of the Gut-Liver Axis in the Progression of Liver Diseases
por: Bruneau, Alix, et al.
Publicado: (2021)

Diagnostic Performance of the Fibrosis-4 Index and Nonalcoholic Fatty Liver Disease Fibrosis Score in Lean Adults With Nonalcoholic Fatty Liver Disease
por: Park, Huiyul, et al.
Publicado: (2023)

The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Cha, Ji-Young, et al.
Publicado: (2018)

Macrophage metabolism in nonalcoholic fatty liver disease
por: Zhang, Wenhui, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease Impairs the Liver–Alpha Cell Axis Independent of Hepatic Inflammation and Fibrosis
por: Pedersen, Julie Steen, et al.
Publicado: (2020)

MicroRNAs in Nonalcoholic Fatty Liver Disease
por: Baffy, György
Publicado: (2015)

Gasdermins in sepsis
por: Wang, Wenhua, et al.
Publicado: (2023)

‘Hints' in the killer protein gasdermin D: unveiling the secrets of gasdermins driving cell death
por: Qiu, Shiqiao, et al.
Publicado: (2017)

Caffeic acid, but not ferulic acid, inhibits macrophage pyroptosis by directly blocking gasdermin D activation
por: Liu, Mingjiang, et al.
Publicado: (2023)

Circulating Citrate Is Associated with Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
por: Amjad, Waseem, et al.
Publicado: (2023)

Gasdermin D in macrophages restrains colitis by controlling cGAS-mediated inflammation
por: Ma, Chunmei, et al.
Publicado: (2020)

MicroRNAs in the Pathogenesis of Nonalcoholic Fatty Liver Disease
por: Fang, Zhiqiang, et al.
Publicado: (2021)

Pyroptosis executor gasdermin D plays a key role in scleroderma and bleomycin-induced skin fibrosis
por: Yang, Huan, et al.
Publicado: (2022)

Association of Non-Invasive Markers with Significant Fibrosis in Patients with Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study
por: Zhang, Fan, et al.
Publicado: (2023)

Lipotoxic hepatocytes promote nonalcoholic fatty liver disease progression by delivering microRNA-9-5p and activating macrophages
por: Liu, Hanyun, et al.
Publicado: (2021)

Long noncoding RNA LCAT1 functions as a ceRNA to regulate RAC1 function by sponging miR-4715-5p in lung cancer
por: Yang, Juze, et al.
Publicado: (2019)

Serum folate associated with nonalcoholic fatty liver disease and advanced hepatic fibrosis
por: Chen, Hao-Kai, et al.
Publicado: (2023)

Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
por: Buzzetti, Elena, et al.
Publicado: (2015)

Estimation of the risk of fibrosis in children with nonalcoholic fatty liver disease
por: Małecki, Paweł, et al.
Publicado: (2020)

Gut-liver axis modulation of Panax notoginseng saponins in nonalcoholic fatty liver disease
por: Xu, Yu, et al.
Publicado: (2021)

Gasdermin D in pyroptosis
por: Burdette, Brandon E., et al.
Publicado: (2021)

CircularRNA circ_0071269 knockdown protects against from diabetic cardiomyopathy injury by microRNA-145/gasdermin A axis
por: Fu, Lanfang, et al.
Publicado: (2022)

MicroRNA regulation of AMPK in nonalcoholic fatty liver disease
por: Sun, Hao, et al.
Publicado: (2023)

Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future
por: Yu, Jung Hwan, et al.
Publicado: (2023)

Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
por: Yu, Su Jong, et al.
Publicado: (2015)

Inhibition of gasdermin D-dependent pyroptosis attenuates the progression of silica-induced pulmonary inflammation and fibrosis
por: Song, Meiyue, et al.
Publicado: (2022)

Intestinal Gasdermins for regulation of inflammation and tumorigenesis
por: Gong, Wenbin, et al.
Publicado: (2022)

Channelling inflammation: gasdermins in physiology and disease
por: Liu, Xing, et al.
Publicado: (2021)

Nitro-fatty acids protect against steatosis and fibrosis during development of nonalcoholic fatty liver disease in mice
por: Rom, Oren, et al.
Publicado: (2019)

Periodontal disease–related nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: An emerging concept of oral‐liver axis
por: Kuraji, Ryutaro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ssuin3ct0u73aaul85c69nv4g4